GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Flora Growth Corp (NAS:FLGC) » Definitions » Gross Profit

Flora Growth (Flora Growth) Gross Profit : $16.25 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Flora Growth Gross Profit?

Flora Growth's gross profit for the three months ended in Mar. 2024 was $3.85 Mil. Flora Growth's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was $16.25 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Flora Growth's gross profit for the three months ended in Mar. 2024 was $3.85 Mil. Flora Growth's Revenue for the three months ended in Mar. 2024 was $18.03 Mil. Therefore, Flora Growth's Gross Margin % for the quarter that ended in Mar. 2024 was 21.37%.

Flora Growth had a gross margin of 21.37% for the quarter that ended in Mar. 2024 => Competition eroding margins

During the past 5 years, the highest Gross Margin % of Flora Growth was 66.98%. The lowest was 21.72%. And the median was 33.34%.


Flora Growth Gross Profit Historical Data

The historical data trend for Flora Growth's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Flora Growth Gross Profit Chart

Flora Growth Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
- 0.07 2.43 13.25 17.74

Flora Growth Quarterly Data
Jun19 Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.35 3.96 4.94 3.49 3.85

Competitive Comparison of Flora Growth's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Flora Growth's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Flora Growth's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Flora Growth's Gross Profit distribution charts can be found below:

* The bar in red indicates where Flora Growth's Gross Profit falls into.



Flora Growth Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Flora Growth's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=76.071 - 58.333
=17.74

Flora Growth's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=18.031 - 14.177
=3.85

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $16.25 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Flora Growth's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=3.85 / 18.031
=21.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Flora Growth  (NAS:FLGC) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Flora Growth had a gross margin of 21.37% for the quarter that ended in Mar. 2024 => Competition eroding margins


Flora Growth Gross Profit Related Terms

Thank you for viewing the detailed overview of Flora Growth's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Flora Growth (Flora Growth) Business Description

Traded in Other Exchanges
N/A
Address
3406 South West 26th Terrace, Suite C-1, Fort Lauderdale, FL, USA, 33132
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company operates in the United States, Germany, Colombia, the United Kingdom, and Canada. it derives a majority of its revenue from the United States.
Executives
Thomas Solomon director C/O FLORA GROWTH CORP., 365 BAY STREET; SUITE 800, TORONTO Z4 M5H 2V1
Kevin Taylor director C/O COOL HOLDINGS, INC., 2001 NW 84TH AVENUE, MIAMI FL 33122
Hussein Rakine director, officer: Chief Executive Officer 5258 SW 183RD AVENUE, MIRAMAR FL 33029
Clifford Starke director, officer: President C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Edward Woo director C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
John Timothy Leslie director C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Marc Mastronardi director C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Jason Warnock officer: CCO C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Annabella Manalo Morgan director C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Jessie Casner officer: CMO C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Dany Vaiman officer: Sr. VP Finance C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Elshad Garayev officer: CFO C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Beverley Richardson director C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Roa Juan Carlos Gomez director C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312
Luis Merchan director, officer: CEO & Chairman of the Board C/O FLORA GROWTH CORP., 3405 SW 26TH TERRACE, SUITE C-1, FORT LAUDERDALE FL 33312